SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
11/9/23 |
| Enright Patrick G |
---|
• | List all Filings as Group Member |
• | Search Recent Filings (as Group Member) for “Patrick G. Enright” |
As Of | Filer | Filings # Latest | Issuer (Primary) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2/13/24 |
| Longitude Capital Partners IV, LLC | 9 | SC 13G |
| Lexeo Therapeutics, Inc. | |||||
10/30/23 |
| Longitude Capital Partners III, LLC | 27 | SC 13D/A |
| Tourmaline Bio, Inc. | |||||
10/18/23 |
| Longitude Capital Partners II, LLC | 26 | SC 13D/A |
| KALA BIO, Inc. | |||||
2/14/22 |
| Longitude Venture Partners II, L.P. | 1 | SC 13G/A |
| Vaxcyte, Inc. | |||||
2/12/19 |
| Longitude Capital Partners, LLC | 24 | SC 13G/A |
| Collegium Pharmaceutical, Inc. |
As Of | Group Member | Filings # Latest | With Filer (Primary) | Issuer (Primary) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/13/24 |
| Juliet Tammenoms Bakker | 87 | SC 13G |
| Longitude Capital Partners IV, LLC |
| Lexeo Therapeutics, Inc. | |||||||
| Longitude Venture Partners IV, L.P. | 12 | |||||||||||||
2/5/24 |
| Longitude Prime Fund, L.P. | 11 | SC 13D/A |
| Longitude Capital Partners IV, LLC |
| Vera Therapeutics, Inc. | |||||||
| Longitude Prime Partners, LLC | 11 | |||||||||||||
10/30/23 |
| Longitude Venture Partners III, L.P. | 27 | SC 13D/A |
| Longitude Capital Partners III, LLC |
| Tourmaline Bio, Inc. | |||||||
10/18/23 |
| Longitude Capital Partners IV, LLC | 3 | SC 13D/A |
| Longitude Capital Partners II, LLC |
| KALA BIO, Inc. | |||||||
| Longitude Venture Partners II, L.P. | 26 | |||||||||||||
2/14/23 |
| Gregory Grunberg | 8 | SC 13D/A |
| Longitude Capital Partners III, LLC |
| 89bio, Inc. | |||||||
2/14/22 |
| Longitude Capital Partners II, LLC | 1 | SC 13G/A |
| Longitude Venture Partners II, L.P. |
| Vaxcyte, Inc. | |||||||
2/14/22 |
| David Hirsch | 11 | SC 13G |
| Longitude Capital Partners II, LLC |
| Rapid Micro Biosystems, Inc. | |||||||
2/4/22 |
| Joshua Richardson | 4 | SC 13D/A |
| Longitude Capital Partners III, LLC |
| Sierra Oncology, Inc. | |||||||
5/21/21 |
| Sandip Agarwala | 1 | SC 13D |
| Longitude Capital Partners III, LLC |
| Tourmaline Bio, Inc. | |||||||
2/12/19 |
| Longitude Capital Associates, L.P. | 24 | SC 13G/A |
| Longitude Capital Partners, LLC |
| Collegium Pharmaceutical, Inc. | |||||||
| Longitude Venture Partners, L.P. | 24 |
• | List all Filings as Signatory |
• | Search Recent Filings (as Signatory) for “Patrick G. Enright” |
As Of | Filer | Filings # Latest | Issuer (Primary) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
11/2/23 |
| Enright Patrick G | 9 | 3 |
| Lexeo Therapeutics, Inc. | |||||
11/2/23 |
| Longitude Capital Partners IV, LLC | 7 | 3 |
| Lexeo Therapeutics, Inc. | |||||
11/2/23 |
| Longitude Venture Partners IV, L.P. | 1 | 3 |
| Lexeo Therapeutics, Inc. | |||||
11/2/23 |
| Tammenoms Bakker Juliet | 2 | 3 |
| Lexeo Therapeutics, Inc. | |||||
10/18/23 |
| Longitude Capital Partners II, LLC | 9 | SC 13D/A |
| KALA BIO, Inc. | |||||
2/14/23 |
| Longitude Capital Partners III, LLC | 13 | SC 13D/A |
| Molecular Templates, Inc. | |||||
3/24/22 |
| Aptinyx Inc. | 5 | S-3 | — | ||||||
3/1/22 | | Jazz Pharmaceuticals plc | 4 | S-8 | — | ||||||
2/14/22 |
| Longitude Venture Partners II, L.P. | 1 | SC 13G/A |
| Vaxcyte, Inc. | |||||
4/23/21 |
| Vera Therapeutics, Inc. | 1 | S-1 | — | ||||||
4/4/08 |
| Longitude Capital Associates, L.P. | 1 | 3 |
| Corcept Therapeutics Inc. | |||||
4/4/08 |
| Longitude Capital Partners, LLC | 1 | 3 |
| Corcept Therapeutics Inc. | |||||
4/4/08 |
| Longitude Venture Partners L.P. | 1 | 3 |
| Corcept Therapeutics Inc. |
As Of | Issuer | Filings # Latest | With Filer (Primary) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
11/2/23 |
| Lexeo Therapeutics, Inc. | 1 | 3 |
| Enright Patrick G | |||||
10/18/23 |
| KALA BIO, Inc. | 2 | SC 13D/A |
| Longitude Capital Partners II, LLC | |||||
5/12/23 |
| Vera Therapeutics, Inc. | 4 | 4 |
| Enright Patrick G | |||||
3/16/23 |
| Aptinyx Inc. | 3 | SC 13D/A |
| Longitude Capital Partners II, LLC | |||||
2/14/23 |
| Molecular Templates, Inc. | 1 | SC 13D/A |
| Longitude Capital Partners III, LLC | |||||
2/14/23 |
| 89bio, Inc. | 3 | SC 13D/A |
| Longitude Capital Partners III, LLC | |||||
2/14/23 |
| Rapid Micro Biosystems, Inc. | 2 | SC 13G/A |
| Longitude Capital Partners II, LLC | |||||
1/3/23 | | Venus Concept Inc. | 1 | SC 13D/A |
| Longitude Capital Partners II, LLC | |||||
5/6/22 |
| Sierra Oncology, Inc. | 3 | SC 13D/A |
| Longitude Capital Partners III, LLC | |||||
4/28/22 |
| Inozyme Pharma, Inc. | 2 | SC 13D/A |
| Longitude Capital Partners III, LLC | |||||
2/14/22 |
| Vaxcyte, Inc. | 2 | SC 13G/A |
| Longitude Venture Partners II, L.P. | |||||
8/13/21 |
| RxSight, Inc. | 1 | SC 13D |
| Longitude Capital Partners II, LLC | |||||
5/27/21 |
| Eargo, Inc. | 3 | SC 13D/A |
| Longitude Capital Partners IV, LLC | |||||
5/21/21 |
| Tourmaline Bio, Inc. | 1 | SC 13D |
| Longitude Capital Partners III, LLC | |||||
1/26/21 |
| Axonics, Inc. | 2 | SC 13D/A |
| Longitude Capital Partners III, LLC | |||||
8/21/20 |
| Checkmate Pharmaceuticals, Inc. | 1 | SC 13D |
| Longitude Capital Partners III, LLC | |||||
8/13/18 | | Jazz Pharmaceuticals plc | 4 | 4 |
| Enright Patrick G | |||||
5/30/17 |
| Aimmune Therapeutics, Inc. | 2 | 4 |
| Enright Patrick G | |||||
4/4/08 |
| Corcept Therapeutics Inc. | 1 | 3 |
| Tammenoms Bakker Juliet |